Evaluation of Renal Perfusion With NIRS in Laparoscopic Surgery

Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06116383
Collaborator
(none)
58
1
5.7
10.2

Study Details

Study Description

Brief Summary

The investigators aimed to show the renal damage caused by increased intra-abdominal pressure in laparoscopic surgeries and to investigate whether its reflection on NIRS would be clinically effective.The main question it aims to answer are:

Does pneumoperitoneum cause renal damage?

NRS monitoring will be performed in patients undergoing laparoscopic surgery. Preoperative and postoperative blood tests will be performed at certain hours. N-GAL, urea and creatinine values will be recorded.

Condition or Disease Intervention/Treatment Phase
  • Device: NIRS

Detailed Description

Renal NIRS monitoring will be performed in patients undergoing laparoscopic cholecystectomy surgery. Age, gender, BMI, ASA scores, hemogblin/hematocrit values, intraoperative hemodynamic parameters, NIRS values, N-GAL (preoperative, 2nd hour and 24th hour), urea/creatinine (preoperative, postoperative 24th hour) values of the patients will be recorded. .

Before the general anesthesia is performed, the renal tissues of the patients will be visualized by ultrasound, the skin-renal cortex distances will be measured, and suitable patients will be included in the study. Basal rSO2 values will be recorded by placing NIRS probes under the 10-11. intercostal space in the bilateral posterior lateral flank region.

Study Design

Study Type:
Observational
Anticipated Enrollment :
58 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Evaluation of Renal Perfusion With NIRS in Adult Patients Undergoing Laparoscopic Cholecystectomy.
Anticipated Study Start Date :
Nov 10, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients undergoing laparoscopic cholecystectomy.

Basal rSO2 values will be recorded by placing NIRS probes under the 10-11th intercostal space in the bilateral posterior lateral flank region. Age, gender, BMI, ASA scores, Hb/Htc values, intraoperative hemodynamic parameters, NIRS values, N-GAL (preoperative, 2nd hour and 24th hour), urea/creatinine (preoperative, postoperative 24th hour) values of the patients will be recorded. .

Device: NIRS
Renal perfusion will be evaluated with NIRS

Outcome Measures

Primary Outcome Measures

  1. Evaluation of renal damage caused by pneumoperitoneum with N-GAL by blood test [During laparoscopic cholecystectomy operation and within 24 hours postoperative]

    Taking a blood test to evaluation N-GAL

  2. Evaluation of renal damage caused by pneumoperitoneum with urea/creatinin by blood test [During laparoscopic cholecystectomy operation and within 24 hours postoperative]

    Taking a blood test to evaluation urea/creatinine values

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who undergoing elective laparoscopic cholecystectomi surgery lasting longer than 60 minutes

  • BMI:18-25

  • skin-renal cortex distance measured less than 4 cm on ultrasound

  • ASA I-III

Exclusion Criteria:
  • patient who did not give consent

  • patient who had renal operation before,

  • infection, abscess, catheter in the perirenal region

  • hemodynamically unstable patients,

  • patients with renal pathology and abnormal kidney function tests,

  • emergency cases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Anesthesiology and Reanimation, University of Health Sciences, Diskapi Yıldırım Beyazit Training and Research Hospital Ankara Turkey 06450

Sponsors and Collaborators

  • Diskapi Yildirim Beyazit Education and Research Hospital

Investigators

  • Study Chair: Savaş Altınsoy, MD, Ankara Etlik City Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Savas Altinsoy, Associate Professor MD, Diskapi Yildirim Beyazit Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT06116383
Other Study ID Numbers:
  • NIRS
First Posted:
Nov 3, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Savas Altinsoy, Associate Professor MD, Diskapi Yildirim Beyazit Education and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2023